Ariz. firm raises funds for study of breast cancer Dx test

04/17/2013 | GenomeWeb Daily News (free registration)

Provista Diagnostics has obtained $6 million in Series A financing, bringing the company's total for that round to $13.5 million. The Scottsdale, Ariz.-based molecular diagnostics firm will use the money in part to conduct prospective clinical studies of its dtectDx Breast system, a breast cancer diagnostic assay that uses protein biomarkers.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT